Suraksha Diagnostic Share Price Today (SURAKSHA)
Today’s Suraksha Stock Read
Suraksha Diagnostic is trading down 0.09% at ₹271.65. With a market cap of ₹1,411.39 Cr, it trades at a P/E of 43.85. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Suraksha Diagnostic is trading down 0.09% at ₹271.65. With a market cap of ₹1,411.39 Cr, it trades at a P/E of 43.85. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Suraksha Diagnostic Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Suraksha Diagnostic Limited, framed against the sector median so the premium or discount is obvious at a glance.
Suraksha Diagnostic Limited trades at a P/E of 43.85× and P/B of 5.76×.
Valuation
Profitability
Growth
Financial Health
Suraksha Diagnostic Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Suraksha Diagnostic Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Suraksha Diagnostic Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Suraksha Diagnostic Limited, switchable between annual and quarterly views, consolidated or standalone.
Suraksha Diagnostic Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,411.39 Cr and reported EPS of ₹6.17.
| Period | 2025 | 2026 |
|---|---|---|
| Revenue from Operations | 252 | 310 |
| Other Income | 4 | 3 |
| Total Income | 256 | 314 |
| Cost of Goods Sold (COGS) | 30 | 36 |
| Gross Profit | 223 | 274 |
| +Operating Expenses | 141 | 179 |
| EBITDA | 81 | 95 |
| +Non-Operating Expenses | 44 | 54 |
| Profit Before Tax (PBT) | 41 | 45 |
| +Tax Expense | 10 | 13 |
| Total Profit for Period | 31 | 31 |
| Less: Non-controlling Interests | -1 | -1 |
| Net Profit (Owner's PAT) | 32 | 32 |
| Earnings Per Share (EPS) | 6.11 | 6.18 |
| Diluted Shares Outstanding (Nos.) | 5 | 5 |
| +Additional Disclosures | 243 | 305 |
| Sales Growth % | — | 23.14 |
| YoY Sales Growth % | — | 23.14 |
| Material Cost % | 12 | 12 |
| Employee Cost % | 17 | 17 |
| Other Cost % | 39 | 40 |
| OPM % | 32 | 31 |
| Tax % | 25 | 30 |
| Profit Growth % | — | 1.14 |
| Gross Margin % | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 |
| +Additional Fields | 46 | 54 |
Suraksha Diagnostic segment analysis: revenue and profit mix.
Disclosed business segments at Suraksha Diagnostic with their share of revenue and profit, switchable between consolidated and standalone reporting.
Suraksha Diagnostic discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Suraksha Diagnostic Limited.
Our AI distills the core fundamental drivers supporting Suraksha Diagnostic Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Suraksha Diagnostic Limited's investment case rests on 10 positive markers and 9 flagged concerns drawn from the latest reported filings.
What you're getting.
Strong operating profit margin at 32.00% indicates efficient core operations.
Robust quarterly sales growth of 19.50% and profit growth of 18.40%.
Low debt-to-equity ratio of 0.42 signifies a healthy financial structure.
Impressive Return on Equity (16.50%) and ROCE (17.80%) show efficient capital use.
Significant promoter holding of 49% reflects strong management confidence.
What can break it.
High P/E ratio of 50.70 suggests potential overvaluation compared to earnings.
Zero dividend yield (0.00%) may not attract income-focused investors.
Declining FII holding from 15.39% to 13.73% signals reduced foreign investor confidence.
Current stock price (323.00) significantly below 52-week high (449.00).
Recent negative stock performance with -2.74% over five days.
What would change my mind.
Trim if P/E re-rates above 57. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.04. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 9%. The operating engine is no longer compounding capital efficiently.
Suraksha Diagnostic Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Suraksha Diagnostic Limited is highlighted for quick read-across.
Quick Compare
Suraksha Diagnostic Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Suraksha Diagnostic Limited — derived from the live tape, not yesterday's close.
Suraksha Diagnostic Limited last traded at ₹271.65 with an intraday range of ₹270.65–₹274.8 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹271.65| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 282.38 | +10.73 | +3.95% |
| R3 | 278.23 | +6.58 | +2.42% |
| R2 | 276.52 | +4.87 | +1.79% |
| R1 | 274.08 | +2.43 | +0.90% |
| PIVOT | 272.37 | 0.72 | 0.26% |
| CURRENT | 271.65 | — | — |
| S1 | 261.63 | -10.02 | -3.69% |
| S2 | 265.78 | -5.87 | -2.16% |
| S3 | 268.22 | -3.43 | -1.26% |
| S4 | 269.93 | -1.72 | -0.63% |
SURAKSHA is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 270.65 ~ 274.75
Trading Inside opening range
Suraksha Diagnostic Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Suraksha Diagnostic Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Suraksha Diagnostic Limited stood at 58.5% of traded volume, against a 20-day average of 55.9%.
Suraksha Diagnostic announcements: results, concalls, ratings, M&A.
Filings Suraksha Diagnostic sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Suraksha Diagnostic files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 59 documents below.
Resignation of Director/KMP/SMP
Suraksha Diagnostic Limited has informed the Exchange about Resignation of Director/KMP/SMP
Cessation
Suraksha Diagnostic Limited has informed the Exchange regarding Cessation of Ms Mamta Jain as Company Secretary & Compliance Officer of the company…
Analysts/Institutional Investor Meet/Con. Call Updates
Suraksha Diagnostic Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates
Suraksha Diagnostic Limited has informed the Exchange about Link of audio recording of the Earnings Call in relation to the audited (standalone and…
Copy of Newspaper Publication
Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
Suraksha Diagnostic insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Suraksha Diagnostic as reported to SEBI — buying and selling signals from the people who know the business best.
Suraksha Diagnostic insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Dr. Somnath Chatterjee | Insider | 13 Jun 2025 | buy | +7.6 K | ₹24.85 L | ₹327.41 |
Suraksha Diagnostic dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Suraksha Diagnostic has declared, sequenced by announce and record date.
Suraksha Diagnostic corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Suraksha Diagnostic Limited: business, sector, key facts.
What Suraksha Diagnostic Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Suraksha Diagnostic Limited operates in the Healthcare Service Provider industry under the Healthcare sector, listed as NSE: SURAKSHA, BSE: 544293.
Suraksha Diagnostic Limited is a prominent player in India's diagnostic healthcare industry, operating a network of diagnostic centers throughout the country. The company's core business revolves around providing a comprehensive suite of diagnostic testing services to patients and healthcare professionals. This wide-ranging portfolio contributes to their significant market presence and caters to a diverse client base.
A significant portion of Suraksha's revenue stems from its pathology testing services. This encompasses a broad spectrum of laboratory analyses, allowing for the detection and diagnosis of various medical conditions. The precise nature and extent of these pathology tests are not detailed in the provided information, but the breadth of services offered is clearly a key component of their business model.
Further enhancing its diagnostic capabilities, Suraksha offers a comprehensive range of radiology services. This includes advanced imaging techniques such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, and Dual-Energy X-ray Absorptiometry (DEXA) scans. These technologies provide detailed internal images of the body, assisting in the diagnosis and monitoring of a variety of health issues. Their radiology offerings also extend to interventional ultrasonography, CT-guided biopsies, and standard X-ray imaging, illustrating a dedication to comprehensive and technologically advanced diagnostic practices.
In addition to its core diagnostic testing services, Suraksha also provides medical consultation services. While the specifics of these services are not detailed, the inclusion of this element suggests an integrated approach to patient care, potentially offering a more holistic and convenient experience by combining diagnostic testing with preliminary medical advice. This could involve consultations with physicians or other healthcare professionals associated with the company.
Established in 1992 and headquartered in Kolkata, India, Suraksha Diagnostic Limited has a long history of serving the healthcare needs of the Indian population. Its continued growth and expansion within the diagnostic services sector demonstrates its success in meeting the demand for accurate and timely diagnostic information.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Health X Platform (HEALTHX) Share PricePeer
- Krsnaa Diagnostics (KRSNAA) Share PricePeer
- Dr Lal Path Labs (LALPATHLAB) Share PricePeer
- Metropolis Healthcare (METROPOLIS) Share PricePeer
- Thyrocare Technologies (THYROCARE) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Suraksha Diagnostic Limited (SURAKSHA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Suraksha Diagnostic Limited (SURAKSHA)?
The current share price of Suraksha Diagnostic Limited (SURAKSHA) is ₹271.65. Today, the stock has declined by ₹0.25 (0.09%), trading in a range of ₹270.65 to ₹274.8. The stock opened at ₹271.9 with a trading volume of 13,541 shares.
02Is Suraksha Diagnostic Limited stock a good investment for long-term?
Suraksha Diagnostic Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,411.39 crores, P/E ratio of 43.85, ROE of 13.84%, and ROCE of 17.80%. The dividend yield stands at 0.18%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Suraksha Diagnostic Limited stock?
The 52-week high price of Suraksha Diagnostic Limited (SURAKSHA) is ₹352.5, while the 52-week low is ₹224.1. Currently trading at ₹271.65, the stock is 37.0% away from its 52-week low and 22.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Suraksha Diagnostic Limited stock at the current price?
Whether to buy Suraksha Diagnostic Limited stock at ₹271.65 depends on multiple factors. The stock is currently trading with a P/E ratio of 43.85 and P/B ratio of 5.76. Today's performance shows a loss of 0.09%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Suraksha Diagnostic Limited and when is the next dividend?
Suraksha Diagnostic Limited offers a dividend yield of 0.18%, which means for every ₹100 invested at the current price of ₹271.65, you can expect to receive approximately ₹0.18 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Suraksha Diagnostic Limited?
Suraksha Diagnostic Limited's key financial metrics include: P/E Ratio: 43.85, P/B Ratio: 5.76, ROE: 13.84%, ROCE: 17.80%, Dividend Yield: 0.18%, EPS: ₹6.17, Book Value: ₹47.17, and Debt-to-Equity: 0.54. The company's market cap stands at ₹1,411.39 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Suraksha Diagnostic Limited stock performing today in the market?
Suraksha Diagnostic Limited stock opened at ₹271.9 and is currently trading at ₹271.65, showing a decline of ₹0.25 (0.09%). The intraday high is ₹274.8 and low is ₹270.65. The trading volume stands at 13,541 shares, indicating moderate market participation today.
08What is the P/E ratio of Suraksha Diagnostic Limited and what does it indicate?
Suraksha Diagnostic Limited has a Price-to-Earnings (P/E) ratio of 43.85, which means investors are willing to pay ₹43.85 for every ₹1 of earnings. With an EPS of ₹6.17, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Suraksha Diagnostic Limited (SURAKSHA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.